Elekta presents mid-term financial targets
Mid-term targets include mid-single-digit CAGR sales and 14–16% adjusted EBIT by FY 2028/29. FY 2026/27 outlook: sales +2–4% and EBIT 12.5–13.5%.
See the latest news and media coverage for Elekta. We track all announcements, press releases, and industry mentions in real time, all in one place.
Precision radiotherapy solutions provider
elekta.comLast updated
In short: Elekta issued new mid-term financial targets and executed a leadership transition following a strategic reorganization and workforce reduction.
Mid-term targets include mid-single-digit CAGR sales and 14–16% adjusted EBIT by FY 2028/29. FY 2026/27 outlook: sales +2–4% and EBIT 12.5–13.5%.
The Nomination Committee recommends reelecting nine directors and electing Cecilia Felton as new board member.
Adjusted EBIT margin rose to 18.9% in Q4, with annualized cost savings exceeding SEK 500 M from operating model reset.
The event occurs on June 17, 2026, at 14:00 CEST with CEO and CFO presentations on strategy and financial targets. Register by June 12.
The radiation therapy company Elekta fell 7% on Wednesday after presenting new financial targets. Management has implemented a number of measures to get both growth and margins in order.
Telenor, CAG Group, Kesko, Salix Group, Norwegian, Hultström, Lea Bank, Polygiene, Spotlight Group, Elekta, Stock Exchange Floor, Column, The Investor, Advice Follow-up and Report Calendar.
Elekta's new targets get cold shoulder on stock exchange – share was down over 7 percent at 1 p.m. Analysts mainly point out the revenue target for the current fiscal year…
SB1 and Handelsbanken believe that growth in the USA is a key factor for Elekta, but have different views of the company's opportunities to reach its new targets.
Track Elekta and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.